REYNALDO PELLA: Open Payments
NPI 1053821405 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,488 in 34 payments from 19 companies in 2025. Trend: 2023 $968 · 2024 $3,232 · 2025 $1,488
Food & beverage: $1,455Education: $32
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $290 |
| CVRx, Inc. | 2 | $189 |
| Recor Medical Inc | 1 | $173 |
| Abbott Laboratories | 3 | $166 |
| AstraZeneca Pharmaceuticals LP | 2 | $135 |
| MEDICOMP INC | 2 | $99 |
| Merck Sharp & Dohme LLC | 5 | $85 |
| LANTHEUS MEDICAL IMAGING, INC. | 3 | $83 |
| Novo Nordisk Inc | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
Products named: Barostim Neo System, Paradise Ultrasound Renal Denervation System, MERLIN@HOME, LOKELMA, TELEPATCH CARDIAC MONITOR, VERQUVO, DEFINITY, Kerendia.
Industry payments across NJ — which companies pay providers there.
